Investigative therapies to treat moderate to severe plaque psoriasis in clinical trials include several orally administered ...

We’ll discuss the distinct traits of psoriatic arthritis in Black patients, and the various environmental and genetic factors ...

Explore the gap between patient and clinician perspectives in psoriatic arthritis care. Learn how priorities differ and why ...

autoantibodies against citrullinated IGF2BP1 are detected in patients with rheumatoid arthritis and positively correlate with disease severity.

This photo shows evidence of damage caused by long-term rheumatoid arthritis which was present before the newer anti-arthritic drugs became widely available. In addition to disease-modifying drugs, ...

SUI was trading within a symmetrical triangle pattern, with a key support level to provide a potential base for upward momentum. A slight dip remains possible as the coin sought stronger support ...

The emergence of new treatments and therapeutic approaches for psoriatic arthritis is improving physicians’ ability to treat a complicated, multifaceted disease. This episode details how ...

The classic signs of rheumatoid arthritis include pain, swelling, and stiffness of several joints. Persistent inflammation can lead to issues with mobility, fatigue, illness, and joint deformity over ...

Arthritis is damage to the cartilage in joints. Shoulder arthritis occurs when the cartilage starts wearing down on the ball and/or socket sides of the shoulder joint. Symptoms of shoulder arthritis ...

About 10%-30% of people with psoriasis will also get psoriatic arthritis. This type of arthritis usually starts between ages 30 and 50 but can start as early as childhood. It's equally common ...

Psoriatic arthritis (PsA) is a chronic inflammatory immune-mediated disease with a burdensome impact on quality of life and substantial healthcare costs. To date, pharmacological interventions with ...